ArticleInternational journal of oncology2024

Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer.

Siyuan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.